# OWC Pharmaceutical Research Corp.

OWC Pharmaceutical Research Corp. is a company headquartered in Ramat Gan, Israel.

## Company overview

- **Legal name:** OWC Pharmaceutical Research Corp.
- **Former names in filing history:** DYNAMIC APPLICATIONS CORP (2008-05-06 to 2014-12-17)
- **Classification:** Company
- **Industry (SIC):** 3841 — Surgical & Medical Instruments & Apparatus
- **Headquarters:** Ramat Gan, Israel
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001431934

## About

OWC Pharmaceutical Research Corp. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001431934, and its reported industry is Surgical & Medical Instruments & Apparatus. In 10-K filed on 2019-04-01, it reported net income of USD -10,258,000; total assets of USD 3,553,000 for the fiscal period ended 2018-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2018 (period ended 2018-12-31)

- **Net income:** -$10.3M (USD -10,258,000)
- **Total assets:** $3.6M (USD 3,553,000)
- **Cash and equivalents:** $3.5M (USD 3,464,000)
- **Operating cash flow:** -$2.5M (USD -2,499,000)

### FY2017 (period ended 2017-12-31)

- **Net income:** -$4.6M (USD -4,558,447)
- **Total assets:** $1.1M (USD 1,061,083)
- **Cash and equivalents:** $970,542 (USD 970,542)
- **Operating cash flow:** -$1.2M (USD -1,185,919)
- **Later filings:** Net income, Total assets, Cash and equivalents, Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2016 (period ended 2016-12-31)

- **Revenue:** $50,000 (USD 50,000)
- **Net income:** -$2.3M (USD -2,287,329)
- **Total assets:** $496,768 (USD 496,768)
- **Cash and equivalents:** $472,282 (USD 472,282)
- **Operating cash flow:** -$529,269 (USD -529,269)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

### FY2015 (period ended 2015-12-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$1.7M (USD -1,654,988)
- **Total assets:** $430,448 (USD 430,448)
- **Operating cash flow:** -$1.2M (USD -1,216,130)

## Recent SEC filings

- Form 8-K — filed 2021-08-25 — period 2021-08-25
- Form SC 13G — filed 2021-06-21 — SCHEDULE 13G
- Form 8-K — filed 2021-03-05 — period 2021-02-26
- Form SC 13D — filed 2021-02-25 — SCHEDULE 13D
- Form 8-K — filed 2020-12-14 — period 2020-12-09
- Form 8-K — filed 2020-09-25 — period 2020-09-23
- Form 8-K — filed 2020-09-16 — period 2020-09-14
- Form 8-K — filed 2020-09-02 — period 2020-08-31
- Form DEF 14A — filed 2020-08-14 — period 2020-08-14
- Form 8-K — filed 2020-06-26 — period 2020-06-25
- Form 8-K — filed 2020-06-24 — period 2020-06-21
- Form 8-K — filed 2020-03-31 — period 2020-03-30

---

Updated: 2026-10-23T19:32:55Z

Canonical page: https://altss.com/profile/owc-pharmaceutical-research-corp

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology